JPMORGAN CHASE & CO

Position in INBX — Inhibrx Biosciences, Inc.

CIK 19617 NEW YORK, NY

Position in INBX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$331,578

-$1,016,083 QoQ

Shares Held

4,932

-71.1% QoQ

Ownership

0.034%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 24.35117599351176.ToString("F0")% Shared 0.ToString("F0")% None 75.64882400648824.ToString("F0")%

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,578,634,665 across 404 Biotechnology names. INBX ranks #203 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	24,150,499	$3,949,089,591
2	REGN	Regeneron Pharmaceuticals, Inc.	4,311,806	$3,331,473,778
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,033,156	$3,140,585,469
4	ALNY	Alnylam Pharmaceuticals, Inc.	6,323,752	$2,092,339,815
5	NUVL	Nuvalent, Inc.	3,088,349	$316,401,351
6	JAZZ	Jazz Pharmaceuticals plc	1,204,353	$227,682,931
7	IONS	Ionis Pharmaceuticals Inc	2,363,567	$177,480,242
8	TERN	Terns Pharmaceuticals, Inc.	2,869,728	$151,292,056

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$331,578	4,932	-71.1%	Shares	Defined	2026-05-13
2025-12-31	$1,347,661	17,059	+253.3%	Shares	Defined	2026-02-11
2025-09-30	$162,640	4,829	-9.0%	Shares	Defined	2025-11-26
2025-06-30	$75,744	5,308	-17.0%	Shares	Defined	2025-08-12
2025-03-31	$89,493	6,397	-15.7%	Shares	Defined	2025-05-12
2024-12-31	$116,915	7,592	+47.8%	Shares	Defined	2025-02-12
2024-09-30	$80,414	5,135	-88.4%	Shares	Defined	2024-12-26
2024-06-30	$627,234	44,265	—	Shares	Defined	2024-12-26
No filing history on record for this holder in this stock.